• Facebook
  • Rss
  • Twitter
  • Youtube
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Year-End MATCH (DEADLINE Dec 31): Donate & Make a Difference | Donate

ProtectOurCare 1024px

ACA Update | September 22, 2017 – Graham-Cassidy Bill: Patient Groups Opposed, McCain Says No, but Threat Continues

September 22, 2017/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Financial Toxicity, Health Care Coverage, Health Equity, Pre-Existing Conditions NCCS News /by actualize

AHCA

Prior to the Affordable Care Act (ACA), cancer survivors were at the mercy of the health care system, often forced to pay exorbitant premiums or simply denied coverage altogether. Today, America’s 16 million cancer survivors benefit from the ACA’s patient protections that are critical to providing them with quality, affordable, and accessible health care coverage. NCCS is actively engaged in advocating to ensure this unprecedented access for cancer patients and providers continues.
Senators Graham and Cassidy are working hard to get their bill, known as the “Graham-Cassidy bill,” passed before the September 30th deadline. The Graham-Cassidy bill would eliminate the ACA’s subsidies and the Medicaid expansion and instead gives block grants to states to create their own individual health systems.

Nearly every patient group, the American Medical Association, AARP, all 50 state Medicaid directors (NAMD), and insurers agree that this bill would be bad for Americans. “Taken together, the per-capita caps and the envisioned block grant would constitute the largest intergovernmental transfer of financial risk from the federal government to the states in our country’s history,” NAMD’s board of directors wrote in a statement Thursday. Friday afternoon, Sen. John McCain (R-AZ) issued a statement saying, “I cannot in good conscience vote for the Graham-Cassidy proposal.” This is a very encouraging development, but we must remain vigilant until Graham-Cassidy is defeated and there no longer exists a threat to repeal the ACA.

“There are so many unknowns about this bill, but one thing is for sure: it would be terrible for patients.”
NCCS had many concerns with the Graham-Cassidy legislation, namely that it eliminates critical patient protections like ensuring those with pre-existing conditions cannot be discriminated against. The ACA banned insurers from charging sick people more than healthy people, and required that all plans include coverage for essential services like prescription drugs and hospital visits (known as essential health benefits). The Graham-Cassidy bill allows states to get rid of these ACA protections, which are absolutely critical to Americans living with cancer and other illnesses. We cannot go back to the days when insurers charged individuals with pre-existing conditions exorbitant premiums for skimpy coverage. This is why it’s critical that you call your Senators today at (844)257-6227 and tell them to vote NO on Graham-Cassidy.

New Analysis: Graham-Cassidy Plan Would Decrease Federal Funding for States by $160 Billion from 2020-2026 https://t.co/slA9nRIfFz pic.twitter.com/GNC52v0j7O

— KFF (Kaiser Family Foundation) (@KFF) September 21, 2017

Not only would this legislation dismantle significant parts of the ACA, but it would also drastically cut health care leaving already money-strapped states to pick up the tab. The block grants are estimated to be $107 billion less than what the federal government would have spent over the period 2020-2026 for ACA coverage. As Kaiser Family Foundation reports, there are winners and losers with the funding formula for the states, and the 31 states that expanded Medicaid will lose significant funding to provide health care to their constituents.

Another concerning aspect of the bill is the fact that the already insufficient block grant funding disappears after 2026. There are so many unknowns about this bill, but one thing is for sure: it would be terrible for patients. Additionally, because Republican leaders are pushing this bill through before the September 30th deadline, the Congressional Budget Office (CBO) will not have enough time for a full score to determine the impacts of this legislation. Senators will likely be voting on this bill without a full picture of its impacts on our nation’s economy, and they will not know how many millions of Americans will be left without insurance if this bill becomes law.

Because cancer survivors would lose critical patient protections and access to comprehensive and affordable coverage, we strongly oppose the bill. Please contact your Senators at (844) 257-6227 to tell them to vote NO on the Graham-Cassidy bill as it would be harmful to cancer patients and survivors. We need a bipartisan and transparent process to strengthen the ACA and help provide critical long-term stability.

For more information on how you can get involved, check out our #ProtectOurCare page »

Follow NCCS on Twitter to stay updated on developments: @CancerAdvocacy.


Related Post

https://canceradvocacy.org/blog/aca-update-sept-20-2017/
https://canceradvocacy.org/blog/aca-update-september-15-2017-cassidy-graham-repeal-plan-devastating-patients-gaining-support-senate/


Tags: aca update, Advocacy, affordable care act, cancer care, Cancer Survivorship, financial issues, Medicaid, pre-existing conditions, repeal and replace
Share this entry
  • Share on Facebook
  • Share on Twitter
https://canceradvocacy.org/wp-content/uploads/2017/01/ProtectOurCare-1024px.jpg 512 1024 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2017-09-22 16:54:432017-09-22 16:54:43ACA Update | September 22, 2017 – Graham-Cassidy Bill: Patient Groups Opposed, McCain Says No, but Threat Continues
You might also like
NCCS Starburst Thumbnail WCOE: Over-Diagnosis, Over-Treatment, and a Broader View of Health
Canceradvocacy org default image NCCS and Cancer Groups Urge National Academy of Medicine to Include Cancer Patients in Phase IB COVID-19 Vaccine Allocation
NCCS Starburst 250px Health Care Roundup: NCCS on Proposed OPPS Changes; Bipartisan Proposal to End ‘Surprise Billing’; Medicaid Work Req’s; Financial Toxicity Survey; More
FacebookProfile3 Some doctors unaware of long-term side effects of cancer care
NCCS Starburst 250px WCOE: Bipartisan Health Care Deal Details; Fertility Banks Underused by Young Male Survivors; Cancer Stress; High Drug Pricing; and More
NCCS News Cancer Policy Matters NCCS Awarded American Institutes for Research Grant to Develop New Outcome Measure: “Return to Functional Status”
NCCS Starburst Thumbnail WCOE: Peter Ubel Explores Healthcare Spending, Surgery Volume & Care Quality, Dr. Dizon Says “I Don’t Know,” and The Survivor Running Biden’s Moonshot
NCCS News Cancer Policy Matters NCCS Strongly Objects to New CMS Waiver Options That Seek to Further Undermine the ACA

Latest News

Coronavirus feat

COVID-19 Vaccines and Cancer: A Conversation with Cancer Expert Otis Brawley, MD

March 1, 2021
The National Coalition for Cancer Survivorship (NCCS) hosted a conversation on February…
Read more
https://canceradvocacy.org/wp-content/uploads/2020/03/Coronavirus-feat.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-03-01 11:49:192021-03-02 16:15:47COVID-19 Vaccines and Cancer: A Conversation with Cancer Expert Otis Brawley, MD
Canceradvocacy org default image

National Quality Forum Names NCCS CEO Shelley Fuld Nasso to 2021 Leadership Consortium Roster

February 24, 2021
NOTE: This press release was originally published on the National Quality Forum (NQF)…
Read more
https://canceradvocacy.org/wp-content/uploads/2019/10/Canceradvocacy-org-default-image.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-02-24 21:01:392021-02-24 21:01:39National Quality Forum Names NCCS CEO Shelley Fuld Nasso to 2021 Leadership Consortium Roster
HHS Humphrey bldg 1200

NCCS and Other Cancer Groups Urge HHS to Keep Six Protected Classes in Medicare Part D Drug Plans

February 19, 2021
The National Coalition for Cancer Survivorship (NCCS) joined with the Cancer Leadership…
Read more
https://canceradvocacy.org/wp-content/uploads/2017/10/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-02-19 15:06:392021-02-24 19:29:10NCCS and Other Cancer Groups Urge HHS to Keep Six Protected Classes in Medicare Part D Drug Plans

Take Action

Stovall Award

The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

“Where you live shouldn’t determine whether you live” – A Letter... Joanna Morales SM OG Fotolia 23428619 S e1461260836640 NCCS Sends Letter to Sen. Finance Committee Opposing Graham-Cassidy ACA Rep...
Scroll to top

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute